Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Oncogene|September 13, 2005
Viruses with deletions in antiapoptotic genes as potential oncolytic agentsTa-Chiang Liu, David KirnCancer Research|January 20, 2007
Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directionsTa-Chiang Liu, David KirnCancer Gene Therapy|January 11, 2003
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to considerRichard Vile, Dale Ando, David KirnCancer Gene Therapy|January 11, 2003
Intravascular adenoviral agents in cancer patients: lessons from clinical trialsTony Reid, Robert Warren, David KirnSeminars in Oncology|December 13, 2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effectsStephen H Thorne, Terry Hermiston, David KirnNature Clinical Practice. Oncology|January 30, 2007
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progressTa-Chiang Liu, Evanthia Galanis, David KirnIranian Biomedical Journal|December 7, 2007
Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument proteinTaravat Bamdad, John C BellCell Cycle (Georgetown, Tex.)|January 16, 2007
Novel therapeutic target: the PERKs of inhibiting the integrated stress responseJaime Blais, John C BellPageof 22